En Es
Categories

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties. Based on the technology platforms of chemiluminescence (CLIA), monotest ELISA, line immunoblot, immunofluorescenc ...
Gold member
Products Covid-19Summary
Close

Covid-19 Shenzhen YHLO Biotech Co., Ltd.

Clinical Laboratory

SARS-CoV-2 IgM & IgG CLIA Assays
iFlash 3000 / iFlash 1800 / iModules

YHLO’s IgG and IgM combined detection is a good supplementary diagnostic tool to PCR, which can identify who are immune to COVID-19 after infection in mass population and its titer change can be used to monitor treatment of COVID-19 patients. Together with iFlash fully automation system, manual work and aerosol contamination risk can be reduced. The assays are CE marked, FDA EUA application accepted and legal export qualification obtained.
More details
Close

About Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties. Based on the technology platforms of chemiluminescence (CLIA), monotest ELISA, line immunoblot, immunofluorescence, YHLO has developed hundreds of test items on autoimmunity, reproductive health, diabetes, infection and routine immunochemistry. YHLO is one of the very few suppliers in China for autoimmune instruments and reagents, and has launched China`s first monotest ELISA analyzer – UNION, China`s first ESR analyzer with direct EDTA tube testing – VISION, China`s first high-speed Chemiluminescence System - iFlash 3000 CLIA System (300 T/H), and China`s first autoimmune assays in CLIA, LIA and ELISA platforms. YHLO has also launched Anti-Müllerian Hormone (AMH) dedicated to ELISA and CLIA systems, as well as the world`s first CLIA assays for Inhibin B, Adiponectin, ZnT8A, RA33, etc. In 2020, YHLO launched CLIA assays of SARS-CoV-2 IgM and IgG to aid the diagnosis of COVID-19.
FaceBook Twitter Google+ Linked in
Immunofluorescence Reader

Immunofluorescence Reader

Model: UNICELL-S
Request Information

Description:

The UNICELL-S immunofluorescence reader delivers results in three to 15 minutes using serum, plasma or whole blood sample types. It features a built-in touch screen and thermal printer, and provides reagent information via ID card and reagent barcode.
Read More

Full Description

Description

The UNICELL-S immunofluorescence reader delivers results in three to 15 minutes using serum, plasma or whole blood sample types. It features a built-in touch screen and thermal printer, and provides reagent information via ID card and reagent barcode. Test items include cTnI/CK-MB/Myo, cTnI, CK-MB, Myo, NT-proBNP, D-Dimer, PCT, CRP, AMH, Inhibin B, HbA1c, 25-OH Vitamin D, etc.
Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Shenzhen YHLO Biotech Co., Ltd. (Immunofluorescence Reader)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions